Article
Identification of diagnostic biomarkers and potential therapeutic drugs in focal segmental glomerulosclerosis with metabolic syndrome by integrating bioinformatics and machine learning
2024-12-24
Abstract excerpt
<title>Abstract</title> <p><bold>Purpose</bold> Immune system dysregulation plays a pivotal role in focal segmental glomerulosclerosis (FSGS) and metabolic syndrome (MS). This study aimed to identify core diagnostic genes and potential therapeutic drugs for FSGS patients with MS. <bold>Methods</bold> We obtained two FSGS and one MS datasets from the GEO database. DEGs and module gene were identified via Limma and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e05d443f-dacf-50ec-ab70-c1a7b6d6d96c
- DOI
- 10.21203/rs.3.rs-5609059/v1
